Lornamead

Form 483 issued April 11, 2023 · Tonawanda, New York

Inspection
Feb 27 – Apr 11, 2023
Investigator
William Leonard
Observations
5
Pages
5
FEI number
1000120219

In short: On April 11, 2023, FDA issued a Form 483 with 5 observations to Lornamead in Tonawanda, New York (FEI 1000120219) after an inspection that ran Feb 27 – Apr 11, 2023. The investigator was William Leonard. Most observations concern quality system and materials.

At a glance

3 of 5 observations on this 483 concern quality system.

Quality system3
Materials1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The identity of each component of a drug product is not verified by conducting at least…

  2. 02

    Complaint procedures are deficient in that they do not include provisions that allow for the review…

  3. 03

    Written records of investigations into unexplained discrepancies and the failure of a batch or any of…

  4. 04

    Equipment for adequate control over temperature is not provided when appropriate for the manufacture, processing, packing…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lornamead?

FDA listed 5 observations on this Form 483, mostly about quality system, materials and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Lornamead?

William Leonard is named on this Form 483, for the inspection of Feb 27 – Apr 11, 2023. Each investigator has a profile showing what they cite most.

When was Lornamead inspected by FDA?

The inspection ran Feb 27 – Apr 11, 2023, and the Form 483 is dated April 11, 2023.

How do I get the full Form 483 for Lornamead?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free